US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist
  • 31.130
  • +1.900+6.50%
Close Nov 27 16:00 ET
  • 31.130
  • 0.0000.00%
Post 20:01 ET
3.17BMarket Cap-8695P/E (TTM)

Dyne Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.48%-74.63M
1.39%-54.87M
-67.43%-78.54M
-22.46%-188.16M
-19.92%-35.01M
-18.22%-50.6M
-80.02%-55.64M
7.55%-46.91M
-28.51%-153.65M
-4.00%-29.19M
Net income from continuing operations
-61.31%-97.13M
-0.31%-65.1M
-48.57%-65.65M
-40.36%-235.94M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.9M
-24.18%-44.19M
-12.60%-168.1M
25.02%-38.83M
Operating gains losses
---26K
--0
-101.42%-2K
314.71%141K
--0
--0
--0
370.00%141K
325.00%34K
--4K
Depreciation and amortization
1.62%438K
-7.42%399K
-6.31%386K
-0.59%1.67M
-0.50%399K
8.56%431K
-6.30%431K
-3.06%412K
54.69%1.68M
17.60%401K
Other non cash items
-18.07%136K
-48.56%125K
-18.01%173K
-52.59%788K
-21.50%168K
122.59%166K
-78.72%243K
-79.73%211K
322.79%1.66M
129.81%214K
Change In working capital
215.09%14.18M
1.05%4.24M
-314.44%-32.83M
589.07%26.31M
395.13%25.53M
187.29%4.5M
-74.34%4.2M
63.57%-7.92M
-158.11%-5.38M
-70.26%5.16M
-Change in prepaid assets
115.44%765K
-156.37%-3.14M
-192.81%-4.07M
180.53%3.34M
707.45%4.12M
-23.96%-4.96M
-62.45%5.57M
91.02%-1.39M
-175.17%-4.14M
-95.49%510K
-Change in payables and accrued expense
41.86%13.41M
640.26%7.38M
-340.33%-28.76M
1,959.92%22.97M
360.85%21.41M
917.29%9.46M
-188.47%-1.37M
-4.20%-6.53M
-109.01%-1.24M
-22.91%4.65M
Cash from discontinued investing activities
Operating cash flow
-47.48%-74.63M
1.39%-54.87M
-67.43%-78.54M
-22.46%-188.16M
-19.92%-35.01M
-18.22%-50.6M
-80.02%-55.64M
7.55%-46.91M
-28.51%-153.65M
-4.00%-29.19M
Investing cash flow
Cash flow from continuing investing activities
-251.34%-19.4M
-35.16%11.17M
-764.54%-179.84M
-4.46%83.31M
36.18%26.2M
-75.18%12.82M
-6.57%17.23M
1,366.95%27.06M
163.24%87.2M
8,285.96%19.24M
Net PPE purchase and sale
-51.50%-253K
-242.80%-857K
16.96%-191K
76.23%-729K
84.20%-82K
81.15%-167K
4.21%-250K
83.58%-230K
15.23%-3.07M
73.92%-519K
Net investment purchase and sale
-247.44%-19.15M
-31.18%12.03M
-758.24%-179.65M
-6.90%84.04M
33.01%26.28M
-75.28%12.99M
-6.53%17.48M
3,813.20%27.29M
167.23%90.27M
1,025.70%19.76M
Cash from discontinued investing activities
Investing cash flow
-251.34%-19.4M
-35.16%11.17M
-764.54%-179.84M
-4.46%83.31M
36.18%26.2M
-75.18%12.82M
-6.57%17.23M
1,366.95%27.06M
163.24%87.2M
8,285.96%19.24M
Financing cash flow
Cash flow from continuing financing activities
3,866.74%18.01M
1,425.18%379.86M
1,317.28%408.39M
45.28%54.32M
-99.60%147K
548.57%454K
25,057.58%24.91M
159,983.33%28.82M
-76.31%37.39M
41,701.12%37.2M
Net common stock issuance
--0
1,455.71%375.58M
1,308.08%397.47M
42.07%52.37M
-100.00%-1K
--0
--24.14M
--28.23M
-76.56%36.86M
--36.86M
Proceeds from stock option exercised by employees
3,866.74%18.01M
460.60%4.28M
1,759.63%10.92M
269.19%1.95M
-56.73%148K
548.57%454K
671.72%764K
3,161.11%587K
-9.42%529K
284.27%342K
Cash from discontinued financing activities
Financing cash flow
3,866.74%18.01M
1,425.18%379.86M
1,317.28%408.39M
45.28%54.32M
-99.60%147K
548.57%454K
25,057.58%24.91M
159,983.33%28.82M
-76.31%37.39M
41,701.12%37.2M
Net cash flow
Beginning cash position
259.04%610.12M
49.35%273.96M
-28.96%123.94M
-14.28%174.47M
-9.93%132.6M
22.88%169.93M
21.75%183.44M
-14.28%174.47M
-32.87%203.52M
-36.47%147.22M
Current changes in cash
-103.67%-76.02M
2,589.40%336.17M
1,572.58%150.01M
-73.91%-50.53M
-131.79%-8.66M
-518.32%-37.33M
-9.19%-13.5M
116.97%8.97M
70.84%-29.05M
196.58%27.25M
End cash Position
302.78%534.1M
259.04%610.12M
49.35%273.96M
-28.96%123.94M
-28.96%123.94M
-9.93%132.6M
22.88%169.93M
21.75%183.44M
-14.28%174.47M
-14.28%174.47M
Free cash flow
-47.50%-74.88M
0.30%-55.73M
-67.02%-78.73M
-20.53%-188.89M
-18.10%-35.09M
-16.20%-50.77M
-79.31%-55.89M
9.59%-47.14M
-27.22%-156.71M
1.15%-29.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.48%-74.63M1.39%-54.87M-67.43%-78.54M-22.46%-188.16M-19.92%-35.01M-18.22%-50.6M-80.02%-55.64M7.55%-46.91M-28.51%-153.65M-4.00%-29.19M
Net income from continuing operations -61.31%-97.13M-0.31%-65.1M-48.57%-65.65M-40.36%-235.94M-71.63%-66.64M-45.49%-60.21M-24.09%-64.9M-24.18%-44.19M-12.60%-168.1M25.02%-38.83M
Operating gains losses ---26K--0-101.42%-2K314.71%141K--0--0--0370.00%141K325.00%34K--4K
Depreciation and amortization 1.62%438K-7.42%399K-6.31%386K-0.59%1.67M-0.50%399K8.56%431K-6.30%431K-3.06%412K54.69%1.68M17.60%401K
Other non cash items -18.07%136K-48.56%125K-18.01%173K-52.59%788K-21.50%168K122.59%166K-78.72%243K-79.73%211K322.79%1.66M129.81%214K
Change In working capital 215.09%14.18M1.05%4.24M-314.44%-32.83M589.07%26.31M395.13%25.53M187.29%4.5M-74.34%4.2M63.57%-7.92M-158.11%-5.38M-70.26%5.16M
-Change in prepaid assets 115.44%765K-156.37%-3.14M-192.81%-4.07M180.53%3.34M707.45%4.12M-23.96%-4.96M-62.45%5.57M91.02%-1.39M-175.17%-4.14M-95.49%510K
-Change in payables and accrued expense 41.86%13.41M640.26%7.38M-340.33%-28.76M1,959.92%22.97M360.85%21.41M917.29%9.46M-188.47%-1.37M-4.20%-6.53M-109.01%-1.24M-22.91%4.65M
Cash from discontinued investing activities
Operating cash flow -47.48%-74.63M1.39%-54.87M-67.43%-78.54M-22.46%-188.16M-19.92%-35.01M-18.22%-50.6M-80.02%-55.64M7.55%-46.91M-28.51%-153.65M-4.00%-29.19M
Investing cash flow
Cash flow from continuing investing activities -251.34%-19.4M-35.16%11.17M-764.54%-179.84M-4.46%83.31M36.18%26.2M-75.18%12.82M-6.57%17.23M1,366.95%27.06M163.24%87.2M8,285.96%19.24M
Net PPE purchase and sale -51.50%-253K-242.80%-857K16.96%-191K76.23%-729K84.20%-82K81.15%-167K4.21%-250K83.58%-230K15.23%-3.07M73.92%-519K
Net investment purchase and sale -247.44%-19.15M-31.18%12.03M-758.24%-179.65M-6.90%84.04M33.01%26.28M-75.28%12.99M-6.53%17.48M3,813.20%27.29M167.23%90.27M1,025.70%19.76M
Cash from discontinued investing activities
Investing cash flow -251.34%-19.4M-35.16%11.17M-764.54%-179.84M-4.46%83.31M36.18%26.2M-75.18%12.82M-6.57%17.23M1,366.95%27.06M163.24%87.2M8,285.96%19.24M
Financing cash flow
Cash flow from continuing financing activities 3,866.74%18.01M1,425.18%379.86M1,317.28%408.39M45.28%54.32M-99.60%147K548.57%454K25,057.58%24.91M159,983.33%28.82M-76.31%37.39M41,701.12%37.2M
Net common stock issuance --01,455.71%375.58M1,308.08%397.47M42.07%52.37M-100.00%-1K--0--24.14M--28.23M-76.56%36.86M--36.86M
Proceeds from stock option exercised by employees 3,866.74%18.01M460.60%4.28M1,759.63%10.92M269.19%1.95M-56.73%148K548.57%454K671.72%764K3,161.11%587K-9.42%529K284.27%342K
Cash from discontinued financing activities
Financing cash flow 3,866.74%18.01M1,425.18%379.86M1,317.28%408.39M45.28%54.32M-99.60%147K548.57%454K25,057.58%24.91M159,983.33%28.82M-76.31%37.39M41,701.12%37.2M
Net cash flow
Beginning cash position 259.04%610.12M49.35%273.96M-28.96%123.94M-14.28%174.47M-9.93%132.6M22.88%169.93M21.75%183.44M-14.28%174.47M-32.87%203.52M-36.47%147.22M
Current changes in cash -103.67%-76.02M2,589.40%336.17M1,572.58%150.01M-73.91%-50.53M-131.79%-8.66M-518.32%-37.33M-9.19%-13.5M116.97%8.97M70.84%-29.05M196.58%27.25M
End cash Position 302.78%534.1M259.04%610.12M49.35%273.96M-28.96%123.94M-28.96%123.94M-9.93%132.6M22.88%169.93M21.75%183.44M-14.28%174.47M-14.28%174.47M
Free cash flow -47.50%-74.88M0.30%-55.73M-67.02%-78.73M-20.53%-188.89M-18.10%-35.09M-16.20%-50.77M-79.31%-55.89M9.59%-47.14M-27.22%-156.71M1.15%-29.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data